Plus   Neg

Ligand Pharmaceuticals Inc Q2 adjusted earnings Beat Estimates

Ligand Pharmaceuticals Inc (LGND) revealed earnings for its second quarter that rose from last year.

The company's profit totaled $73.16 million, or $2.99 per share. This compares with $6.06 million, or $0.26 per share, in last year's second quarter.

Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $60.57 million or $2.59 per share for the period.

Analysts had expected the company to earn $2.34 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 221.6% to $90.04 million from $28.00 million last year.

Ligand Pharmaceuticals Inc earnings at a glance:

-Earnings (Q2): $60.57 Mln. vs. $14.94 Mln. last year.
-EPS (Q2): $2.59 vs. $0.67 last year.
-Analysts Estimate: $2.34
-Revenue (Q2): $90.04 Mln vs. $28.00 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT